| Literature DB >> 20923842 |
Tinne Smets1, Johan Bilsen, Joachim Cohen, Mette L Rurup, Freddy Mortier, Luc Deliens.
Abstract
OBJECTIVES: To estimate the rate of reporting of euthanasia cases to the Federal Control and Evaluation Committee and to compare the characteristics of reported and unreported cases of euthanasia. Design Cross sectional analysis. Setting Flanders, Belgium. PARTICIPANTS: A stratified at random sample was drawn of people who died between 1 June 2007 and 30 November 2007. The certifying physician of each death was sent a questionnaire on end of life decision making in the death concerned. MAIN OUTCOME MEASURES: The rate of euthanasia cases reported to the Federal Control and Evaluation Committee; physicians' reasons for not reporting cases of euthanasia; the relation between reporting and non-reporting and the characteristics of the physician and patient; the time by which life was shortened according to the physician; the labelling of the end of life decision by the physician involved; and differences in characteristics of due care between reported and unreported euthanasia cases.Entities:
Mesh:
Year: 2010 PMID: 20923842 PMCID: PMC2950259 DOI: 10.1136/bmj.c5174
Source DB: PubMed Journal: BMJ ISSN: 0959-8138
Reporting rates for euthanasia in Flanders, Belgium, in 2007
| Number of cases | Rate | |
|---|---|---|
| Estimated number of cases of euthanasia | 137 | — |
| Estimated number of reported cases of euthanasia | 549 | — |
| Estimated weighted total number of cases of euthanasia* | 1040 | 1.9% (1.6% to 2.3%)† |
| Overall reporting rate for euthanasia‡ | 52.8% (43.9% to 60.5%)† | |
| Reporting rates for euthanasia according to drug use‡§ | ||
| Recommended drugs¶ | 70 | 92.9% (84.3% to 96.5%) |
| Non-recommended drugs** | 61 | 4.8% (1.1% to 16.9%) |
*The estimated total rate of euthanasia was calculated by weighting for stratification and for patient and mortality characteristics of all deaths in 2007.25 The original number of euthanasia cases in the sample was 137. One case was missing data on the variable “reporting of end of life decision.”
†Percent of all deaths in Flanders, Belgium, 2007.25
‡Weighted percentage.
§Five “missings” on the variable “drugs used for euthanasia.”
¶Barbiturates, neuromuscular relaxants, or both.
**Opioids, benzodiazepines, or other drugs other than barbiturates or neuromuscular relaxants.
Reporting of euthanasia according to characteristics of physician and patient, time by which life was shortened, and labelling of the end of life decision*
| All cases (n=137; weighted n)† | Cases reported to review committee (n=72) | P value‡ | ||
|---|---|---|---|---|
| Weighted n | Weighted percentage of cases (95% CI) | |||
| Type of physician | ||||
| General practitioner | 80 | 43 | 53.8 (41.5 to 65.4) | 0.863 |
| Specialist | 56 | 29 | 51.8 (34.3 to 69.1) | |
| Sex | ||||
| Male | 83 | 43 | 51.8 (38.3 to 64.9) | 0.727 |
| Female | 54 | 30 | 55.6 (39.3 to 70.0) | |
| Age | ||||
| 18-49 | 12 | 8 | 66.7 (31.7 to 90.0) | 0.001§ |
| 50-64 | 37 | 23 | 62.2 (42.2 to 77.8) | |
| 65-79 | 60 | 36 | 60.0 (45.3 to 72.8) | |
| ≥80 | 28 | 6 | 21.4 (9.1 to 40.4) | |
| Educational attainment | ||||
| Primary school | 20 | 7 | 35.0 (13.1 to 64.4) | 0.309 |
| Lower secondary school | 40 | 24 | 60.0 (41.2 to 75.8) | |
| Higher secondary school or higher | 37 | 21 | 58.8 (37.5 to 75.0) | |
| Unknown | 41 | 21 | 51.2 (35.1 to 67.9) | |
| Living situation | ||||
| Alone | 24 | 15 | 62.5 (40.6 to 80.5) | 0.432 |
| In private household | 98 | 50 | 51.0 (39.1 to 63.0) | |
| In institution | 10 | 4 | 40.0 (9.9 to 83.3) | |
| Place of death | ||||
| Home | 66 | 37 | 56.1 (43.3 to 68.3) | 0.874 |
| Hospital | 59 | 30 | 50.8 (34.1 to 67.6) | |
| Care home | 5 | 2 | 40.0 (13.3 to 77.8) | |
| Other | 6 | 3 | 50.0 (7.6 to 91.4) | |
| Diagnosis | ||||
| Malignant disease | 111 | 58 | 52.3 (42.3 to 61.9) | 0.002§ |
| Cardiovascular disease | 5 | 0 | 0.0 (0.0 to 0.0) | |
| Disease of the nervous system | 7 | 6 | 85.7 (34.3 to 98.1) | |
| Disease of the respiratory system | 6 | 2 | 33.3 (4.5 to 85.9) | |
| Other disease | 5 | 5 | 100.0 (100 to 100) | |
| <24 hours | 13 | 2 | 15.4 (4.8 to 40.1) | <0.001§ |
| 1-7 days | 60 | 25 | 41.7 (27.6 to 57.5) | |
| 1-4 weeks | 35 | 21 | 60.0 (35.1 to 80.5) | |
| 1-6 months | 16 | 16 | 100.0 (100 to 100) | |
| >6 months | 6 | 5 | 83.3 (44.0 to 98.8) | |
| Euthanasia | 72 | 67 | 93.1 (85.1 to 96.6) | <0.001§ |
| Palliative or terminal sedation | 48 | 2 | 6.3 (1.5 to 21.6) | |
| Non-treatment decision | 8 | 2 | 25.0 (1.8 to 78.6) | |
| Alleviation of symptoms | 8 | 0 | 0.0 (0.0 to 30.1) | |
*Percentages are row percentages. All percentages and total numbers are adjusted for stratification, and to patient/mortality characteristics of all deaths in 2007, which makes the percentages representative for all deaths in Flanders in 2007. Total numbers may not always amount to 137 because of rounding or missing values on variables. Percentages may not always amount to 100 because of rounding.
†One case was missing data on the variable “reporting of end of life decision.”
‡P value for reported cases versus cases not reported.
§P<0.05 using Fisher’s Exact (Monte Carlo).
Characteristics of due care for reported and unreported cases of euthanasia*
| All cases (n=137)‡ | Cases reported to review committee (n=72) | Unreported cases (n=64) | P value | ||||
|---|---|---|---|---|---|---|---|
| Weighted n | Weighted percentage of cases (95% CI) | Weighted n | Weighted percentage of cases (95% CI) | Weighted n | Weighted percentage of cases (95% CI) | ||
| Verbal request only | 68 | 50.0 (40.1 to 60.5) | 13 | 17.6 (9.1 to 31.5) | 55 | 87.7 (76.6 to 93.9) | <0.001† |
| Written request only | 9 | 6.6 (2.3 to 18.0) | 7 | 9.3 (2.4 to 29.9) | 2 | 3.7 (0.9 to 14.5) | |
| Verbal and written request | 58 | 43.3 (33.5 to 53.1) | 53 | 73.1 (56.8 to 84.9) | 5 | 8.6 (3.9 to 18.0) | |
| Total | 126 | 93.3 (80.2 to 97.8) | 72 | 100 (100 to 100) | 54 | 85.2 (63.0 to 95.1) | 0.001† |
| Other physician | 106 | 77.0 (66.2 to 85.7) | 71 | 97.5 (88.1 to 99.5) | 35 | 54.6 (38.7 to 69.6) | <0.001† |
| Care giver specialised in palliative care | 67 | 49.1 (39.2 to 59.6) | 46 | 63.9 (49.6 to 76.2) | 21 | 33.0 ( 21.3 to 47.2) | <0.001† |
| Nursing staff | 72 | 53.5 (42.8 to 63.3) | 39 | 54.3 (40.5 to 67.5) | 33 | 51.9 (36.6 to 66.9) | 0.864 |
| Relative | 106 | 77.5 (66.0 to 85.8) | 57 | 78.4 (63.6 to 88.4) | 49 | 76.2 ( 57.4 to 88.4) | 0.841 |
| Other persons | 8 | 5.9 (2.9 to 11.9) | 7 | 9.1 (4.2 to 18.7) | 1 | 2.3 (0.3 to 15.0) | 0.068 |
| Neuromuscular relaxant§ | 15 | 11.2 (6.5 to 18.9) | 15 | 22.1 (12.8 to 35.0) | 0 | — | <0.001† |
| Barbiturate¶ | 21 | 15.7 (10.5 to 23.2) | 18 | 26.5 (16.6 to 38.5) | 3 | 4.8 (1.8 to 13.0) | |
| Neuromuscular relaxant and barbiturate** | 34 | 26.6 (17.7 to 36.8) | 32 | 47.1 (34.0 to 61.9) | 2 | 3.2 (1.0 to 10.3) | |
| Opioids†† | 60 | 45.5 (35.5 to 56.4) | 3 | 4.4 (1.0 to 15.4) | 57 | 90.5 (80.2 to 94.8) | |
| Other drug | 1 | 1.0 (0.2 to 4.1) | 0 | — | 1 | 1.6 (0.5 to 8.3) | |
| Physician | 96 | 72.2 (60.8 to 81.0) | 69 | 97.9 (86.5 to 99.7) | 27 | 43.0 (29.0 to 58.3) | <0.001† |
| Nurse | 26 | 19.3 (11.7 to 30.4) | 0 | — | 26 | 41.3 (26.3 to 57.5) | |
| Physician and nurse | 9 | 7.4 (3.2 to 16.2) | 1 | 2.1 (0.3 to 13.5) | 8 | 13.4 (5.3 to 29.7) | |
| Physician and other person | 2 | 1.2 (0.3 to 4.8) | 0 | — | 2 | 2.6 (0.6 to 10.0) | |
*All percentages are adjusted for stratification and for patient and mortality characteristics of all deaths in 2007, which makes the percentages representative for all deaths in Flanders in 2007.
†P<0.05, using Fisher’s Exact (Monte Carlo).
‡One case was missing data on the variable “reporting of end of life decision.” Total numbers may not always amount to 137 because of rounding or missing values on variables. Percentages may not always amount to 100 because of rounding.
§ Neuromuscular relaxant alone or in conjunction with benzodiazepine, opioids, or other drug other than barbiturate.
¶Barbiturate alone or in conjunction with benzodiazepine, opioids, or other drug other than muscle relaxant.
**Neuromuscular relaxant and barbiturate, alone or in conjunction with benzodiazepine, opioids, or other drug.
††Opioids alone or in conjunction with benzodiazepine or other drug other than barbiturate or neuromuscular relaxant.